Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
4,535,836
-
Share change
-
+1,018,996
-
Total reported value
-
$76,981,825
-
Put/Call ratio
-
109%
-
Price per share
-
$16.97
-
Number of holders
-
63
-
Value change
-
+$13,306,834
-
Number of buys
-
41
-
Number of sells
-
34
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q2 2017
As of 30 Jun 2017,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
63 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,535,836 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, CITADEL ADVISORS LLC, Marshall Wace North America L.P., JPMORGAN CHASE & CO, Mirae Asset Global Investments Co., Ltd., DEUTSCHE BANK AG\, CITIGROUP INC, STATE STREET CORP, and Pennsylvania Trust Co.
This page lists
63
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.